For the quarter ending 2026-03-31, ALMR made $26,035K in revenue. -$21,325K in net income. Net profit margin of -81.91%.
| Income Statement | 2026-03-31 | |||
|---|---|---|---|---|
| Total revenue | 26,035 | |||
| Product | 9,810 | |||
| Service Other | 1,768 | |||
| Total cost of revenue | 11,578 | |||
| Gross profit | 14,457 | |||
| Research and development | 13,017 | |||
| Selling, general and administrative | 13,787 | |||
| Total operating expenses | 26,804 | |||
| Loss from operations | -12,347 | |||
| Interest income, net | 539 | |||
| Interest expense | 223 | |||
| Loss on remeasurement of convertible notes | 8,594 | |||
| Other (expense) income, net | -236 | |||
| Net loss before income tax | -20,861 | |||
| Provision for income taxes | 464 | |||
| Net loss | -21,325 | |||
| Basic EPS | -1.74 | |||
| Diluted EPS | -1.74 | |||
| Basic Average Shares | 12,259,811 | |||
| Diluted Average Shares | 12,259,811 | |||
Alamar Biosciences, Inc. (ALMR)
Alamar Biosciences, Inc. (ALMR)